COMBINATION DRUG THERAPIES WITH THE NOVEL RNA POLYMERASE I INHIBITOR CX-5461 IMPROVE EFFICACY IN THE TREATMENT OF MULTIPLE MYELOMA

被引：0
|
作者：
Maclachlan, K. [1 ,2 ]
Cuddihy, A. [1 ]
Hein, N. [3 ]
Harrison, S. [2 ]
Hannan, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] Peter MacCallum Canc Ctr, Res Div, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Australian Natl Univ, Dept Canc Biol & Therapeut, Canberra, ACT, Australia
[4] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia
[6] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia
[7] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1240
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [21] Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
    Quin, Jaclyn
    Chan, Keefe T.
    Devlin, Jennifer R.
    Cameron, Donald P.
    Diesch, Jeannine
    Cullinane, Carleen
    Ahern, Jessica
    Khot, Amit
    Hein, Nadine
    George, Amee J.
    Hannan, Katherine M.
    Poortinga, Gretchen
    Sheppard, Karen E.
    Khanna, Kum Kum
    Johnstone, Ricky W.
    Drygin, Denis
    McArthur, Grant A.
    Pearson, Richard B.
    Sanij, Elaine
    Hannan, Ross D.
    ONCOTARGET, 2016, 7 (31) : 49800 - 49818
  • [22] CX-5461, a non-genotoxic activator of p53 through selective inhibition of RNA polymerase I for the treatment of hematological cancers
    Drygin, Denis
    Ho, Caroline
    Bliesath, Josh
    Proffitt, Chris
    Bywater, Megan
    Hannan, Ross
    McArthur, Grant
    O'Brien, Sean
    Rice, William G.
    Anderes, Kenna
    CANCER RESEARCH, 2011, 71
  • [23] The Synthesis and Biological Evaluation of Some C-9 and C-10 Substituted Derivatives of the RNA Polymerase I Transcription Inhibitor CX-5461
    Amarasiri, Madushani
    Vo, Yen
    Gardiner, Michael G.
    Poh, Perlita
    Soo, Priscilla
    Pavy, Megan
    Hein, Nadine
    Ferreira, Rita
    Hannan, Katherine M.
    Hannan, Ross D.
    Banwell, Martin G.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2021, 74 (07) : 540 - 556
  • [24] First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
    Khot, Amit
    Brajanovski, Natalie
    Cameron, Donald P.
    Hein, Nadine
    Maclachlan, Kylee H.
    Sanij, Elaine
    Lim, John
    Soong, John
    Link, Emma
    Blombery, Piers
    Thompson, Ella R.
    Fellowes, Andrew
    Sheppard, Karen E.
    McArthur, Grant A.
    Pearson, Richard B.
    Hannan, Ross D.
    Poortinga, Gretchen
    Harrison, Simon J.
    CANCER DISCOVERY, 2019, 9 (08) : 1036 - 1049
  • [25] Therapeutic Targeting of RNA Polymerase I With the Small-Molecule CX-5461 for Prevention of Arterial Injury-Induced Neointimal Hyperplasia
    Ye, Qing
    Pang, Shu
    Zhang, Wenjing
    Guo, Xiaotong
    Wang, Jianli
    Zhang, Yongtao
    Liu, Yang
    Wu, Xiao
    Jiang, Fan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (03) : 476 - +
  • [26] Proffered Paper: Inhibition of RNA Polymerase I transcription by CX-5461 as a completely new approach to treat highly refractory haematological malignancies
    Hannan, R.
    Hein, N.
    O'Brien, S. E.
    Drygin, D.
    Cullinane, C.
    Matthews, G.
    Johnstone, R. W.
    Pearson, R. B.
    McArthur, G.
    Harrison, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S17 - S17
  • [27] A novel formulation of CX-5461, a small-molecule inhibitor of rRNA synthesis, and its use for treatment of acute myeloid leukemia models
    Leung, Ada W. Y.
    Anantha, Malathi
    Prosser, Kathleen E.
    Wehbe, Mohamed
    Walsby, Charles J.
    Bally, Marcel B.
    CANCER RESEARCH, 2016, 76
  • [28] The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability
    Mars, Jean-Clement
    Tremblay, Michel G.
    Valere, Melissa
    Sibai, Dany S.
    Sabourin-Felix, Marianne
    Lessard, Frederic
    Moss, Tom
    NAR CANCER, 2020, 2 (04):
  • [29] Inhibition of RNA Polymerase I transcription by CX-5461 as a therapeutic strategy for the cancer-specific activation of p53 in highly refractory haematological malignancies
    Hein, Nadine
    Drygin, Denis
    O'Brien, Sean
    Cullinane, Carleen
    Matthews, Geoff
    Chesi, Marta
    Bergsagel, Leif
    Zuber, Johannes
    Lowe, Scott
    Johnstone, Ricky
    Pearson, Rick
    McArthur, Grant
    Hannan, Ross
    CANCER RESEARCH, 2013, 73
  • [30] The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer
    Shunfei Yan
    Jiachen Xuan
    Natalie Brajanovski
    Madeleine R. C. Tancock
    Piyush B. Madhamshettiwar
    Kaylene J. Simpson
    Sarah Ellis
    Jian Kang
    Carleen Cullinane
    Karen E. Sheppard
    Katherine M. Hannan
    Ross D. Hannan
    Elaine Sanij
    Richard B. Pearson
    Keefe T. Chan
    British Journal of Cancer, 2021, 124 : 616 - 627
12345